Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
GW 501516
Cat. No.:
OB0225LY-0412
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
GW 501516 is a selective agonist that acts primarily on PPARδ receptors involved in lipid metabolism and energy homeostasis.
Synonym:
Cardarine; GW501516; GW 1516; GSK-516; Endurobol; 317318-70-0; 2-(4-((2-(4-(Trifluoromethyl)phenyl)-4-methylthiazol-5-yl)methylthio)-2-methylphenoxy)acetic acid; 2-[2-Methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid
CAS No.:
317318-70-0
Compound CID:
9803963
Formula:
C21H18F3NO3S2
Formula Weight:
453.5
Specification
Relative Density:
1.426 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
GW 501516 can be used to study its role in fat metabolism and exercise endurance improvement.
Library Information
Targets:
PPAR
Receptors:
PPARβ; PPARδ
Pathways:
Metabolism; Autophagy; DNA damage/DNA repair
Plate Number:
AOCL-6
Plate Location:
c8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
75 mg/mL; 165.38 mM
